Allworth Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $455K | Buy |
20,972
+20,705
| +7,755% | +$449K | ﹤0.01% | 860 |
|
|
2025
Q1 | $6.19K | Hold |
267
| – | – | ﹤0.01% | 2643 |
|
|
2024
Q4 | $6.11K | Sell |
267
-94
| -26% | -$2.15K | ﹤0.01% | 2660 |
|
|
2024
Q3 | $7.18K | Hold |
361
| – | – | ﹤0.01% | 2408 |
|
|
2024
Q2 | $6.12K | Buy |
361
+109
| +43% | +$1.85K | ﹤0.01% | 2425 |
|
|
2024
Q1 | $4.02K | Sell |
252
-19
| -7% | -$303 | ﹤0.01% | 2498 |
|
|
2023
Q4 | $4.56K | Buy |
271
+246
| +984% | +$4.14K | ﹤0.01% | 2308 |
|
|
2023
Q3 | $293 | Buy |
+25
| New | +$293 | ﹤0.01% | 3175 |
|
|
2023
Q1 | – | Sell |
-68
| Closed | -$1.27K | – | 3210 |
|
|
2022
Q4 | $1.27K | Buy |
68
+4
| +6% | +$74 | ﹤0.01% | 2395 |
|
|
2022
Q3 | $1K | Buy |
+64
| New | +$1K | ﹤0.01% | 2343 |
|